[Radiological biomarkers of brain gliomas].

Autor:	Tyurina AN; Burdenko Neurosurgery Center, Moscow, Russia., Vikhrova NB; Burdenko Neurosurgery Center, Moscow, Russia., Batalov AI; Burdenko Neurosurgery Center, Moscow, Russia., Kalaeva DB; Burdenko Neurosurgery Center, Moscow, Russia.; Moscow Engineering Physics Institute, Moscow, Russia., Shults EI; Research Practical Clinical Center of Diagnosis and Telemedicine Technologies, Moscow, Russia., Postnov AA; Burdenko Neurosurgery Center, Moscow, Russia.; Moscow Engineering Physics Institute, Moscow, Russia.; Lebedev Physical Institute, Moscow, Russia., Pronin IN; Burdenko Neurosurgery Center, Moscow, Russia.
Jazyk:	English; Russian
Zdroj:	Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko [Zh Vopr Neirokhir Im N N Burdenko] 2022; Vol. 86 (6), pp. 121-126.
DOI:	10.17116/neiro202286061121
Abstrakt:	The most important objective of modern neuroimaging is comparison of data on genotype and phenotype of brain gliomas. Radiogenomics as a new branch of science is devoted to searching for such relationships based on MRI and PET/CT parameters. The 2021 WHO classification of tumors of the central nervous system poses the most important tasks for physicians in assessment of biological behavior of tumors and their response to combined treatment. The review demonstrates the possibilities and prospects of preoperative MRI and PET/CT with amino acids in assessing the genetic profile of brain gliomas.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu